BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 7506802)

  • 1. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
    Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
    Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Four cases of CD7-positive acute myeloid leukemia].
    Tomiyama J; Mitsuhashi S; Kudo H; Adachi Y
    Rinsho Ketsueki; 1993 Jan; 34(1):57-62. PubMed ID: 8450609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD7 positive acute myelogenous leukemia exhibiting pleural involvement as an initial manifestation].
    Ohe K; Okamura T; Arima F; Kamura T; Takamatsu Y; Murakawa M; Okamura S; Harada M; Niho Y
    Rinsho Ketsueki; 1994 Jun; 35(6):552-6. PubMed ID: 7521403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
    Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
    Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia.
    O'Connor R; Cesano A; Kreider BL; Lange B; Clark SC; Nowell PC; Finan J; Rovera G; Santoli D
    J Immunol; 1990 Dec; 145(11):3779-87. PubMed ID: 2246514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
    Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
    Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
    Knapp W; Strobl H; Majdic O
    Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: involvement of common leukemic progenitors and their developmental abnormality of "lineage infidelity".
    Akashi K; Harada M; Shibuya T; Fukagawa K; Kimura N; Sagawa K; Yoshikai Y; Teshima T; Kikuchi M; Niho Y
    J Cell Physiol; 1991 Sep; 148(3):446-56. PubMed ID: 1655817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Smoldering leukemia with CD7.CD34(+), immunoglobulin heavy chain rearrangement (+) and hypoplastic marrow with myelofibrosis].
    Hara T; Tsurumi H; Yamada T; Sawada M; Naito T; Murakami N; Moriwaki H; Muto Y
    Rinsho Ketsueki; 1997 Jan; 38(1):21-7. PubMed ID: 9028157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular and biological characterization of CD7-positive acute leukemia cells--an investigation of the established cell line, HSM911].
    Iwasaki H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):750-66. PubMed ID: 7525434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.